1 / 22

Case presentation Rheumatology

Case presentation Rheumatology . History. 39 yr old female pt, unemployed from Bloemfontein Routine follow up at rheumatology Background history of hypertension Diagnosis of ? Mixed connective tissue disease/ Overlap syndrome/ seronegative rheumatoid arthritis

faxon
Download Presentation

Case presentation Rheumatology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Case presentationRheumatology

  2. History • 39 yr old female pt, unemployed from Bloemfontein • Routine follow up at rheumatology • Background history of hypertension • Diagnosis of • ? Mixed connective tissue disease/ Overlap syndrome/ seronegative rheumatoid arthritis • Previous serology: ANF, AntiRNP, Scl 70, Anti Jo, elevated CK’s

  3. History(cont..) • Severe generalised joint pains • No associated swelling reported • Morning stiffness • Constitutional symptoms • Dryness of the eyes • No other systemic complaints • Sober habits

  4. History(cont..) • Medication list: • MTX 20 mg /week • Nivaquine 200mg daily • Prednisone 10mg daily • Folate 5mg daily • Ridaq 12.5mg daily • Pharmapress 20 mg daily po • Losec 20 mg daily po • Voltaren • Dolorol forte

  5. Clinical examination • General examination: • In discomfort due to pain • No pallor/jaundice/adenopathy • No vasculitic or skin changes • Systemic exam: • CVS: haemodynamically stable • Resp: clear • GIT: no tenderness or organomegaly • M/S: bilateral symmetrical tenderness and warmth of joints in upper and lower extremities. No effusions.

  6. Evaluation • Assessment • Flare of arthritis • Management • DepoMedrol 160 mg imi stat • Bloods for : • Inflammatory markers • AST/ALT/Alb • Methotrexate increased to 25 mg/week

  7. Evaluation(cont..)

  8. Differential diagnosis • Drug induced hepatitis • Viral hepatitis • Autoimmune hepatitis(AIH)

  9. Differential diagnosis(cont..) • Patient admitted for evaluation • Reports good response to steroids • Methotrexate stopped • Follow up blood results

  10. Investigations • Virological studies • Hepatitis A, B and C studies were negative • HIV negative • Serology • ANA , ANCA negative • Anti smooth muscle Ab’s unfortunately not done • SPEP • Normal • Abdominal ultrasound • Normal

  11. Diagnostic challenge ?

  12. Hepatitis in autoimmune disease • Causes related to: • Underlying autoimmune disease • Concurrent infections • Chronic viral hepatitis • Opportunistic infections • Drug related toxicity • Methotrexate • Azathioprine • Other causes • Alcoholic liver disease • Metabolic disorders • Malignancy

  13. Autoimmune hepatitis • Cell-mediated immunologic attack against genetically predisposed hepatocytes • Progressive necroinflammatory and fibrotic process. • Association with other autoimmune diseases • Rheumatologic conditions • Rheumatoid arthritis and Felty syndrome • Sjögren syndrome • Systemic sclerosis • Mixed connective-tissue disease

  14. Autoimmune hepatitis • Presentation is heterogeneous, and clinical manifestations vary • Asymptomatic • Debilitating symptoms • Fulminant hepatic failure • Women are affected more often than men (70-80% of patients are women) • Response to steroid and/or immunosuppressive therapy

  15. Autoimmune hepatitis

  16. Drug induced hepatotoxicity • Risk factors associated with drug induced liver injury • Age: elderly at high risk • Sex: more common in females • Alcohol use • Underlying liver disease • Co- morbid disease • Pregnancy • Other drugs • Genetic factors

  17. Methotrexatehepatotoxicity • Methotrexate can induce: • hepatocyte necrosis • Increased ALT • Hepatic fibrosis and cirrhosis • Common setting in pt treated for psoriasis

  18. Methotrexate toxicity(cont..) Premethotrexate Evaluation Complete blood count with differential countPlatelet countSerum creatinineUrea UrinalysisLiver function tests Serum bilirubinSerum albuminHepatitis A, B, and C serologiesHIV risk assessment/testing, if appropriateChest radiograph Information from Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am AcadDermatol 1998; 38:478-85.

  19. Methotrexate toxicity(cont..) • Indications for liver biopsy in pt with RA • Persistently elevated liver enzymes • Abnormal results in five of nine determinations of AST levels within a 12-month period( done 4-8 weekly) • Decrease in serum albumin values below the normal range • Not cost-effective in the first 10 years in pt’s with normal enzymes • Presence of moderate fibrosis/cirrhosis warrants discontinuation

  20. Our patient AIH MTH hepatotoxicity • Female gender • Underlying autoimmune disorder • Previous +ANA • ?Response of transaminases to steroids • Hepatocellular injury pattern in pt on MTX • ?Other possible precipitating factor • ?Did pt increase her treatment due to pain

  21. Our patient • Decline in LFT’s to near normal • MTX stopped indefinately • Prednisone increased to 20 mg • For reevaluation in 2/52, ?liver biopsy

More Related